Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Vertex Pharmaceuticals (VRTX) operate in?

Vertex Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Vertex Pharmaceuticals Stock (NASDAQ: VRTX) stock price, news, charts, stock research, profile.

Open	$459.59
Close	$462.99
Volume / Avg.	1.42M / 1.15M
Day Range	$456.07 - $466.09
52 Wk Range	341.85 - 510.64
Market Cap	$119.50B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	40
Short Interest	1.7%
Days to Cover	4.31

Recent News

Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics

Jim Cramer discusses Serve Robotics, Builders FirstSource, Vertex Pharmaceuticals and Viking Therapeutics on CNBC.

Avi Kapoor

NSA Code Breaker Jim Simons' Hedge Fund Renaissance Technologies — Ozempic, Wegovy Maker Novo Nordisk Along With Nvidia, Palantir Among Top Holdings

Renaissance Technologies, the hedge fund founded by legendary mathematician and former NSA code breaker Jim Simons, recently disclosed its latest stock holdings in a 13F filing with the U.S. Securities and Exchange Commission on Aug. 9.

Kaustubh Bagalkote

Editas Q2 Earnings & Revenues Miss Estimates, Stock Down

Editas Medicine, Inc. (NASDAQ: EDIT) incurred a loss of 82 cents per share in the second quarter of 2024, wider than the Zacks Consensus Estimate of a loss of 69 cents. The company had reported a loss of 56 cents per share in the year-ago quarter.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Jul

Aug

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$459.59
Close	$462.99
Volume / Avg.	1.42M / 1.15M
Day Range	$456.07 - $466.09
52 Wk Range	341.85 - 510.64
Market Cap	$119.50B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	40
Short Interest	1.7%
Days to Cover	4.31

About Vertex Pharmaceuticals, Inc.

Sector

Health Care

Industry

Biotechnology

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Vertex Pharmaceuticals (VRTX) stock?

You can purchase shares of Vertex Pharmaceuticals (NASDAQ:VRTX) through any online brokerage.

View our list of the best stock brokerages

Who are Vertex Pharmaceuticals (VRTX) competitors?

Other companies in Vertex Pharmaceuticals’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Roivant Sciences (NASDAQ:ROIV).

What is the forecast, or price target, for Vertex Pharmaceuticals (VRTX) stock?

Vertex Pharmaceuticals has a consensus price target of $488.25.

What is the current price for Vertex Pharmaceuticals (VRTX)?

The stock price for Vertex Pharmaceuticals (NASDAQ: VRTX) is $462.99 last updated September 24, 2024 at 4:24 PM EDT.

Does Vertex Pharmaceuticals (VRTX) pay a dividend?

There are no upcoming dividends for Vertex Pharmaceuticals.

When is Vertex Pharmaceuticals (NASDAQ:VRTX) reporting earnings?

Vertex Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 4, 2024.

Is Vertex Pharmaceuticals (VRTX) going to split?

There is no upcoming split for Vertex Pharmaceuticals.

What sector and industry does Vertex Pharmaceuticals (VRTX) operate in?

Vertex Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Top Stock Ideas Sent Daily — Join and Gain Your Edge